Target intelligence / Profile preview

Colonic microbiota

Molecular classification
Other
01

Overview

The **colonic microbiota** refers to the complex community of microorganisms—including bacteria (primarily anaerobes), archaea, fungi, viruses—that inhabit the human colon. This ecosystem is distinct from other regions in the gastrointestinal tract due to its high density and unique composition. The colonic microbiota plays critical roles in digestion by fermenting indigestible fibers into short-chain fatty acids; protecting against pathogenic organisms through competitive exclusion and production of antimicrobial substances; regulating local and systemic immune responses; maintaining epithelial barrier integrity; synthesizing certain vitamins; influencing metabolism; and even affecting neurological functions via the gut–brain axis. Disruption in this community’s balance—termed dysbiosis—has been linked to various diseases including inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), colorectal cancer (CRC), metabolic disorders such as obesity or diabetes, infections like C. difficile colitis, among others. While modulation of the colonic/gut microbiota is an emerging therapeutic strategy using approaches such as probiotics/prebiotics administration or fecal transplantation—and some drugs can alter its composition—the **colonic microbiota itself is not a single molecular entity** but rather a population-level ecological system composed mainly of diverse bacterial species. Thus it does **not fit standard definitions for a druggable molecular target** like receptors or enzymes. **Key note:** "Colonic microbiota" is *not* a single molecule/receptor/protein/enzyme/transporter but rather an entire microbial ecosystem within the colon. It cannot be classified under typical therapeutic targets used in pharmacology/structural biology databases because it lacks singular structure/function characteristics required for those categories.

Other names
Gut microbiotagut floraintestinal microbiotacolonic floragut microflora
02

Mechanism of action

*Not applicable as a molecular target.* However, interventions act by modulating microbial composition or activity through antibiotics, probiotics/prebiotics, or fecal transplantation.

03

Biological functions

Metabolism of dietary compoundsProtection against pathogensRegulation of immune functionMaintenance of intestinal epitheliumModulation of inflammationSynthesis of essential nutrients (e.g., short-chain fatty acids)Interaction with the gut–brain axis
04

Disease associations

Inflammatory bowel disease (IBD)Irritable bowel syndrome (IBS)Colon cancer/colorectal cancer (CRC)InfectionDysbiosis-related disorders
05

Safety considerations

Therapeutic manipulation can cause dysbiosis or infection if harmful bacteria overgrow.Fecal transplants carry risks such as transmission of infectious agents.Broad-spectrum antibiotics may disrupt beneficial microbes leading to secondary infections like Clostridioides difficile.
06

Interacting drugs

Antibiotics (broad class; not specific drugs)

2 more in the full profile.

07

Biomarkers

Potential microbial species associated with disease states include Fusobacterium nucleatum, Parvimonas micra, Porphyromonas asaccharolytica, Bacteroides fragilis for CRC riskClostridium and Roseburia as protective markersMicrobial diversity and abundance profiles are being explored as biomarkers for IBD and CRC.

Beyond the preview

Go deeper on Colonic microbiota.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Colonic microbiota.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call